Latest Articles
Amy Schumer, Julianne Hough & More Open Up About Hidden Health Battle - iHeart
Amy Schumer, Julianne Hough & More Open Up About Hidden Health Battle iHeart
Published: June 4, 2026, 11:09 p.m.
Amy Schumer, Julianne Hough & More Open Up About Hidden Health Battle - 101.3 KDWB
Amy Schumer, Julianne Hough & More Open Up About Hidden Health Battle 101.3 KDWB
Published: June 4, 2026, 10:55 p.m.
Amy Schumer, Julianne Hough & More Open Up About Hidden Health Battle - 104.7 KISS FM Phoenix
Amy Schumer, Julianne Hough & More Open Up About Hidden Health Battle 104.7 KISS FM Phoenix
Published: June 4, 2026, 10:55 p.m.
Amy Schumer, Julianne Hough & More Open Up About Hidden Health Battle - Y100.7
Amy Schumer, Julianne Hough & More Open Up About Hidden Health Battle Y100.7
Published: June 4, 2026, 10:55 p.m.
Clinical pearls into ACOG's postmenopausal bleeding guidelines with Susan Loeb-Zeitlin, MD, FACOG - Contemporary OB/GYN
Clinical pearls into ACOG's postmenopausal bleeding guidelines with Susan Loeb-Zeitlin, MD, FACOG Contemporary OB/GYN
Published: June 4, 2026, 9:30 p.m.
Famous women are opening up about their endometriosis struggles - MSN
Famous women are opening up about their endometriosis struggles MSN
Published: June 4, 2026, 1:48 p.m.
Endometriosis: The hidden disease behind painful periods - PressReader
Endometriosis: The hidden disease behind painful periods PressReader
Published: June 4, 2026, 7:44 a.m.
A Key Endometriosis & Breast Cancer Drug Is Being Pulled From Australia: 'Deeply Concerned' - pedestrian.tv
A Key Endometriosis & Breast Cancer Drug Is Being Pulled From Australia: 'Deeply Concerned' pedestrian.tv
Published: June 4, 2026, 5:34 a.m.
5 doctors on the referral misfires creating clinical friction in their specialty—are you guilty of any? - MDLinx
5 doctors on the referral misfires creating clinical friction in their specialty—are you guilty of any? MDLinx
Published: June 3, 2026, 6:25 p.m.
Addition of Pembrolizumab to Chemotherapy Continues to Demonstrate Overall Survival Benefit in Advanced or Recurrent Endometrial Cancer - The ASCO Post
Addition of Pembrolizumab to Chemotherapy Continues to Demonstrate Overall Survival Benefit in Advanced or Recurrent Endometrial Cancer The ASCO Post
Published: June 3, 2026, 2:49 p.m.
Link copied to clipboard!